| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.17 | 0.003 |